CDEK
← All trials

NCT06286059

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Mar 7, 2024
Primary completion
Dec 31, 2024
Completion date
Jan 31, 2025
First posted
Feb 29, 2024
Last posted
Mar 18, 2024
Enrollment
60
Arms / groups
2 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.